DiRocco Derek has filed 19 insider transactions across 4 companies since February 2023.
Most recent transaction: a grant/award of 6200 shares of Mineralys Therapeutics, Inc. ($MLYS) on February 19, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 19, 2026 | Mineralys Therapeutics, Inc. | $MLYS | DiRocco Derek | Director | A | Common Stock | 6200 | $0.00 | 6,200.0000 | 79,139,956 | 9999.99% | 0.01% |
| Feb. 19, 2026 | Mineralys Therapeutics, Inc. | $MLYS | DiRocco Derek | Director | A | Stock Option | 8300 | $0.00 | 8,300.0000 | 79,139,956 | 9999.99% | 0.01% |
| Oct. 30, 2025 | 89bio, Inc. | $ETNB | DiRocco Derek | Not found | D | Stock Option (Right to Buy) | 12500 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.01% |
| Oct. 30, 2025 | 89bio, Inc. | $ETNB | DiRocco Derek | Not found | D | Stock Option (Right to Buy) | 7000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.00% |
| Oct. 30, 2025 | 89bio, Inc. | $ETNB | DiRocco Derek | Not found | D | Stock Option (Right to Buy) | 7000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.00% |
| Oct. 30, 2025 | 89bio, Inc. | $ETNB | DiRocco Derek | Not found | D | Stock Option (Right to Buy) | 25000 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.02% |
| Oct. 30, 2025 | 89bio, Inc. | $ETNB | DiRocco Derek | Not found | D | Stock Option (Right to Buy) | 27400 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.02% |
| Oct. 30, 2025 | 89bio, Inc. | $ETNB | DiRocco Derek | Not found | D | Stock Option (Right to Buy) | 45150 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.03% |
| Oct. 30, 2025 | 89bio, Inc. | $ETNB | DiRocco Derek | Not found | D | Stock Option (Right to Buy) | 56400 | $0.00 | 0.0000 | 157,880,203 | 100.00% | 0.04% |
| June 13, 2025 | Acrivon Therapeutics, Inc. | $ACRV | DiRocco Derek | Not found | A | Stock Option (Right to Buy) | 20275 | $0.00 | 20,275.0000 | 33,791,817 | 9999.99% | 0.06% |
| Feb. 13, 2025 | Mineralys Therapeutics, Inc. | $MLYS | DiRocco Derek | Director | A | Stock Option | 32900 | $0.00 | 32,900.0000 | 49,835,637 | 9999.99% | 0.07% |
| Feb. 3, 2025 | 89bio, Inc. | $ETNB | DiRocco Derek | Not found | A | Stock Option (Right to Buy) | 56400 | $0.00 | 56,400.0000 | 104,714,613 | 9999.99% | 0.05% |
| June 20, 2024 | Acrivon Therapeutics, Inc. | $ACRV | DiRocco Derek | Not found | A | Stock Option (Right to Buy) | 20275 | $0.00 | 20,275.0000 | 22,078,190 | 9999.99% | 0.09% |
| May 24, 2024 | Werewolf Therapeutics, Inc. | $HOWL | DiRocco Derek | Not found | A | Stock Option (right to buy) | 17500 | $0.00 | 17,500.0000 | 0 | 9999.99% | 0.00% |
| May 22, 2024 | Mineralys Therapeutics, Inc. | $MLYS | DiRocco Derek | Director | A | Stock Option | 22000 | $0.00 | 22,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2024 | 89bio, Inc. | $ETNB | DiRocco Derek | Not found | A | Stock Option (Right to Buy) | 45150 | $0.00 | 45,150.0000 | 71,172,870 | 9999.99% | 0.06% |
| June 21, 2023 | Werewolf Therapeutics, Inc. | $HOWL | DiRocco Derek | Director | A | Stock Option (right to buy) | 13200 | $0.00 | 13,200.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2023 | 89bio, Inc. | $ETNB | DiRocco Derek | Director | A | Stock Option (Right to Buy) | 27400 | $0.00 | 27,400.0000 | 34,806,349 | 9999.99% | 0.08% |
| Feb. 9, 2023 | Mineralys Therapeutics, Inc. | $MLYS | DiRocco Derek | Director | A | Common Stock | 44000 | $0.00 | 44,000.0000 | 0 | 9999.99% | 0.00% |